<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 24 May 2021 17:25:04 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>人福1类新药批了！千亿市场国产新药崛起，海思科、恒瑞、科伦……火速入局</title><link>https://mp.weixin.qq.com/s/ZcUyeLJG_Hs5hQ2HEYc6pw</link><description></description><content:encoded><![CDATA[人福1类新药批了！千亿市场国产新药崛起，海思科、恒瑞、科伦……火速入局]]></content:encoded><pubDate>Mon, 24 May 2021 16:31:57 +0800</pubDate></item><item><title>【重磅】2021“中国医药·品牌榜”评选活动正式启动！</title><link>https://mp.weixin.qq.com/s/63M3YNmzJ04HmkMMbkvRug</link><description></description><content:encoded><![CDATA[【重磅】2021“中国医药·品牌榜”评选活动正式启动！]]></content:encoded><pubDate>Mon, 24 May 2021 16:31:57 +0800</pubDate></item><item><title>【火爆】50亿注射剂大品种，倍特、一品红……4家同日过评</title><link>https://mp.weixin.qq.com/s/bGAJlP_JdduOqc9Awvu0aw</link><description></description><content:encoded><![CDATA[【火爆】50亿注射剂大品种，倍特、一品红……4家同日过评]]></content:encoded><pubDate>Mon, 24 May 2021 16:31:57 +0800</pubDate></item><item><title>【数据】鼻炎用药零售市场前五品牌稳定，外资仍占主导</title><link>https://mp.weixin.qq.com/s/YB7DORs5QnFDT3xnxAiVFw</link><description></description><content:encoded><![CDATA[【数据】鼻炎用药零售市场前五品牌稳定，外资仍占主导]]></content:encoded><pubDate>Mon, 24 May 2021 16:31:57 +0800</pubDate></item><item><title>开拓药业：股价逆风飞扬的背后</title><link>https://mp.weixin.qq.com/s/I2yBKZqhmyXJwHmhZdMmig</link><description></description><content:encoded><![CDATA[开拓药业：股价逆风飞扬的背后]]></content:encoded><pubDate>Sun, 23 May 2021 07:47:47 +0800</pubDate></item><item><title>超5000家药企“大限将至”，医疗机构采购或被叫停！63个未过评的国采未中选药品将撤网</title><link>https://mp.weixin.qq.com/s/rAlcdH1dODAcJZdDMFX2cw</link><description></description><content:encoded><![CDATA[超5000家药企“大限将至”，医疗机构采购或被叫停！63个未过评的国采未中选药品将撤网]]></content:encoded><pubDate>Sat, 22 May 2021 08:04:37 +0800</pubDate></item><item><title>【瞩目】科伦开挂了！50亿注射剂过评，1类新药再次亮相ASCO</title><link>https://mp.weixin.qq.com/s/hoT99ktm2vyUucjU2tJ34g</link><description></description><content:encoded><![CDATA[【瞩目】科伦开挂了！50亿注射剂过评，1类新药再次亮相ASCO]]></content:encoded><pubDate>Fri, 21 May 2021 16:24:07 +0800</pubDate></item><item><title>【审评】20亿大品种，信立泰将拿下</title><link>https://mp.weixin.qq.com/s/_iNsnapHu71HYreNN6veKA</link><description></description><content:encoded><![CDATA[【审评】20亿大品种，信立泰将拿下]]></content:encoded><pubDate>Fri, 21 May 2021 16:24:07 +0800</pubDate></item><item><title>【市场】常见安眠药！山东药企首家过评</title><link>https://mp.weixin.qq.com/s/uOkliy2NKKrH_a8jxHmUWA</link><description></description><content:encoded><![CDATA[【市场】常见安眠药！山东药企首家过评]]></content:encoded><pubDate>Fri, 21 May 2021 16:24:07 +0800</pubDate></item><item><title>化药TOP20洗牌！4大产品亮了，两个百亿品种跌落，扬子江逆袭，正大天晴、石药爆发</title><link>https://mp.weixin.qq.com/s/7cPDVw-z2iIi-jEQ6SeM0Q</link><description></description><content:encoded><![CDATA[化药TOP20洗牌！4大产品亮了，两个百亿品种跌落，扬子江逆袭，正大天晴、石药爆发]]></content:encoded><pubDate>Thu, 20 May 2021 16:10:21 +0800</pubDate></item><item><title>【重磅】国产胰岛素龙头发力，30亿大品种将获批</title><link>https://mp.weixin.qq.com/s/ephgtX62uGgztzPnzUaRYg</link><description></description><content:encoded><![CDATA[【重磅】国产胰岛素龙头发力，30亿大品种将获批]]></content:encoded><pubDate>Thu, 20 May 2021 16:10:21 +0800</pubDate></item><item><title>【瞩目】北京药企将拿下国产首个！原研产品暴涨超100%</title><link>https://mp.weixin.qq.com/s/KIZ20berjiSicK2WhWikZg</link><description></description><content:encoded><![CDATA[【瞩目】北京药企将拿下国产首个！原研产品暴涨超100%]]></content:encoded><pubDate>Thu, 20 May 2021 16:10:21 +0800</pubDate></item><item><title>【聚焦】东阳光药首仿迎劲敌！石药、扬子江抢国产第2家</title><link>https://mp.weixin.qq.com/s/kq6554XnOiH38uY6lyzJ5A</link><description></description><content:encoded><![CDATA[【聚焦】东阳光药首仿迎劲敌！石药、扬子江抢国产第2家]]></content:encoded><pubDate>Thu, 20 May 2021 16:10:21 +0800</pubDate></item><item><title>惊呆了，药企55亿净利润“狂砸”67亿现金分红！丽珠、恒瑞、片仔癀……超50家豪气派钱</title><link>https://mp.weixin.qq.com/s/1G0m-A8y6-sCcBytQsA5xg</link><description></description><content:encoded><![CDATA[惊呆了，药企55亿净利润“狂砸”67亿现金分红！丽珠、恒瑞、片仔癀……超50家豪气派钱]]></content:encoded><pubDate>Wed, 19 May 2021 17:35:13 +0800</pubDate></item><item><title>【业绩】合揽超500亿营收！大参林、老百姓5大上市连锁战略曝光</title><link>https://mp.weixin.qq.com/s/mYHnm9zwfoVmu5WYqzk4QA</link><description></description><content:encoded><![CDATA[【业绩】合揽超500亿营收！大参林、老百姓5大上市连锁战略曝光]]></content:encoded><pubDate>Wed, 19 May 2021 17:35:13 +0800</pubDate></item><item><title>【获批】暴涨超300%注射剂！恒瑞拿下首家过评</title><link>https://mp.weixin.qq.com/s/OrLWx8lbpBVyqgltkTyZRg</link><description></description><content:encoded><![CDATA[【获批】暴涨超300%注射剂！恒瑞拿下首家过评]]></content:encoded><pubDate>Wed, 19 May 2021 17:35:13 +0800</pubDate></item><item><title>【热点】第五批国采！50亿大品种，基药与集采规格不一致引关注？</title><link>https://mp.weixin.qq.com/s/mz7MSSfExr6njws-_tq_Lg</link><description></description><content:encoded><![CDATA[【热点】第五批国采！50亿大品种，基药与集采规格不一致引关注？]]></content:encoded><pubDate>Wed, 19 May 2021 17:35:13 +0800</pubDate></item><item><title>2021米思会第一轮议程发布</title><link>https://mp.weixin.qq.com/s/G-P0fkTQIULECra0ViWvww</link><description></description><content:encoded><![CDATA[2021米思会第一轮议程发布]]></content:encoded><pubDate>Tue, 18 May 2021 16:23:22 +0800</pubDate></item><item><title>【重磅】2020中国医药工业百强榜评选启动，研发创新+专业推广“双轮驱动”</title><link>https://mp.weixin.qq.com/s/cDfOEOfKvfl2IHV_fFGVfQ</link><description></description><content:encoded><![CDATA[【重磅】2020中国医药工业百强榜评选启动，研发创新+专业推广“双轮驱动”]]></content:encoded><pubDate>Tue, 18 May 2021 16:23:22 +0800</pubDate></item><item><title>【瞩目】苑东发威！抢$10亿大品种首仿</title><link>https://mp.weixin.qq.com/s/pr-L7Ne2NvQRhEdDL4wOMQ</link><description></description><content:encoded><![CDATA[【瞩目】苑东发威！抢$10亿大品种首仿]]></content:encoded><pubDate>Tue, 18 May 2021 16:23:22 +0800</pubDate></item></channel></rss>